Atezolizumab + Beva...
 
Notifications
Clear all

Atezolizumab + Bevacizumab --- Unresectable Hepatocellular Carcinoma


Kimster
(@kimster)
Joined: 1 year ago
Posts: 115
Topic starter  

Hi friends, just sharing the following:

 

https://www.eurekalert.org/pub_releases/2021-02/sh-dg020221.php

Drug 'breakthrough' gives longest-ever survival in nonresectable liver cancer patients

NEWS RELEASE: 05 FEB 2021

:

:

:

Atezolizumab is an immune checkpoint inhibitor drug, which helps the immune system hunt down and destroy cancer.

Bevacizumab is a targeted monoclonal antibody therapy that starves tumours of their blood supply by preventing endothelial growth but also enhances the immune effects of atezolizumab.

:

:

:

The combination provides the longest survival seen in a front-line Phase III study in advanced HCC, confirming atezo+bev as a standard of care for previously untreated, unresectable HCC."

"These are highly significant findings for the treatment of patients with HCC.

Many thousands of patients worldwide could benefit from this treatment and it can be considered a major breakthrough - the first improvement in treatment for these types of cases in 13 years and a treatment long awaited by doctors."

:

:

:

 

 

Thanks.

Kimster


Quote
Share: